GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stayble Therapeutics AB (STU:4K4) » Definitions » Float Percentage Of Total Shares Outstanding

Stayble Therapeutics AB (STU:4K4) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Stayble Therapeutics AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Stayble Therapeutics AB's float shares is 0.00 Mil. Stayble Therapeutics AB's total shares outstanding is 31.72 Mil. Stayble Therapeutics AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Stayble Therapeutics AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Stayble Therapeutics AB's Institutional Ownership is 0.01%.

Stayble Therapeutics AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Stayble Therapeutics AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/31.72
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stayble Therapeutics AB (STU:4K4) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stayble Therapeutics AB (STU:4K4) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:ACTI XSAT:HAMLET B OSTO:SPRINT OSTO:ISOFOL OSTO:ABLI OSTO:ELIC OSTO:ALZ OSTO:BIOVIC B OSTO:NXTCL OSTO:BIOWKS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
STABL:Sweden 4K4:Germany
Address
Medicinaregatan 8a, Gothenburg, SWE, SE-413 90
Website
http://www.staybletherapeutics.com
Stayble Therapeutics AB is a clinical-stage pharmaceutical company developing STA363, an intradiscally injected formulation against chronic discogenic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and analgesics. The injection is given once and the effect is expected to remain throughout the patient's life and requires minimal rehabilitation. The company's injection treatment, STA363, is expected to correct the underlying cause of disc-related low back pain by affecting the two main causative factors namely instability of the disc and prevention of leakage of inflammatory mediators from the disc center.

Stayble Therapeutics AB (STU:4K4) Headlines

No Headlines